EGFL7 and neoplasm: EGFL7 controls intercellular and cell–matrix communication, which are key features of tumor progression and metastasis, by hijacking the receptor tyrosine kinase epidermal growth factor receptor (EGFR), integrin, and Notch signaling pathways [6,7,8].